research use only
Cat.No.S2003
| Related Targets | Integrase Bacterial Antibiotics Anti-infection Fungal Antiviral COVID-19 Parasite Reverse Transcriptase HIV |
|---|---|
| Other CCR Inhibitors | Cenicriviroc INCB3344 SB-297006 ZK756326 2HCl BX471 (ZK-811752) Adaptavir (DAPTA) R243 RS102895 BMS-813160 AZD2098 |
|
In vitro |
DMSO
: 100 mg/mL
(194.67 mM)
Ethanol : 100 mg/mL Water : Insoluble The solubility data above are all experimental results (not literature values). |
|
In vivo |
|||||
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such
as vortex, ultrasound or hot water bath can be used to aid dissolving.
Read more about Maraviroc (UK-427857) solubility in DMSO or water
Read more about Maraviroc (UK-427857) working concentrations for cell culture treatment
| Information | Maraviroc (UK-427857) is a potent, allosteric CCR5 antagonist. It affects CCL5/CCR5 and PI3K/AKT signaling pathways by binding to the receptor's transmembrane domain and stabilizing its inactive conformation, effectively inhibiting HIV-1 entry, macrophage polarization, and inflammation. |
|---|---|
|
Read more about Maraviroc (UK-427857) IC50 for cell-based and cell-free assays |
|
| Primary Applications and Mechanism of Action | |
| Molecular Weight | 513.67 | Formula | C29H41F2N5O |
Storage (From the date of receipt) | |
|---|---|---|---|---|---|
| CAS No. | 376348-65-1 | Download SDF | Storage of Stock Solutions |
|
|
| Synonyms | UK-427857 | Smiles | CC1=NN=C(N1C2CC3CCC(C2)N3CCC(C4=CC=CC=C4)NC(=O)C5CCC(CC5)(F)F)C(C)C | ||
Tel: +1-832-582-8158 Ext:3
If you have any other enquiries, please leave a message.
Question 1:
What vehicle do you recommend to dissolve it for in vivo experiments?
Answer:
It can be dissolved in 5% DMSO/castor oil at 62 mg/ml as suspension for oral administration. As to a clear solution for injection, following three vehicles at 10mg/ml will help: 1. 2% DMSO/castor oil; 2. 2%DMSO/sunflower oil; 3. 2%DMSO/30%PEG 300/ddH2O.